Prelude Therapeutics Share Price (NASDAQ: PRLD)
$1.23
Live
Last updated on
Check the interactive Prelude Therapeutics Stock chart to analyse performance
Prelude Therapeutics stock performance
as on August 30, 2025 at 12:38 am IST
- Today's Low:$1.18Today's High:$1.24
4.07%
Downside
Day's Volatility :4.84%
Upside
0.81%
- 52 Weeks Low:$0.6152 Weeks High:$5.53
50.4%
Downside
52 Weeks Volatility :88.97%
Upside
77.76%
Prelude Therapeutics Stock Returns
Prelude Therapeutics Inc Key Stats
Check Prelude Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Prelude Therapeutics Stock including INR - Dollar returns
The Prelude Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Prelude Therapeutics investment value today
Current value as on today
₹28,831
Returns
Returns from Prelude Therapeutics Stock
Dollar Returns*
₹5,177 (+5.18%)
Indian investors sentiment towards Prelude Therapeutics Stock
Global Institutional Holdings in Prelude Therapeutics Inc
Name
Holdings %
SG Americas Securities, LLC
0.03%
Analyst Recommendation on Prelude Therapeutics Stock
Sell
11%Buy
44%Hold
44%Sell
Based on 9 Wall street analysts offering stock ratings for Prelude Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Prelude Therapeutics Share Price Target
What analysts predicted
Upside of 184.55%
Target:
$3.50
Current:
$1.23
Prelude Therapeutics share price target is $3.50, a slight Upside of 184.55% compared to current price of $1.23 as per analysts' prediction.
Prelude Therapeutics Stock Insights
Price Movement
In the last 1 month, PRLD stock has moved up by 55.1%PRLD vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 57.5% return, outperforming this stock by 132.7%PRLD vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.3% return, outperforming this stock by 199.5%Price to Sales
ForPRLD every $1 of sales, investors are willing to pay $14.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.8 for every $1 of sales.
Prelude Therapeutics Technicals Summary
Sell
Neutral
Buy
Prelude Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Prelude Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 57.34% | 69.96% | -75.19% | -81.88% | -95.08% |
 | 3.77% | -17.64% | -51.18% | -2.19% | -7.17% |
 | -0.02% | 10.33% | 51.07% | 81.16% | 24.14% |
 | -16.39% | -18.24% | -20.49% | 39.42% | 40.54% |
 | 33.05% | 83.22% | 57.52% | 115.32% | 240.85% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -1.3 | -0.96 | -0.5 | NA | 1.34 |
| 14.79 | 14.79 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.69 | 27.69 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Sell | $72.4M | -95.08% | NA | 0.0% |
| Buy | $62.2B | -7.17% | 14.79 | 31.37% |
| NA | $36.8B | 24.14% | NA | -3.89% |
| Buy | $99.8B | 40.54% | 27.69 | 31.86% |
| Buy | $59.1B | 240.85% | NA | -12.96% |
About Prelude Therapeutics Inc
Key Management of Prelude Therapeutics Inc
Important FAQs about investing in PRLD Stock from India :
What is Prelude Therapeutics share price today?
Prelude Therapeutics share price today is $1.23 as on . Prelude Therapeutics share today touched a day high of $1.24 and a low of $1.18.
What is the 52 week high and 52 week low for Prelude Therapeutics share?
Prelude Therapeutics share touched a 52 week high of $5.53 and a 52 week low of $0.61. Prelude Therapeutics stock price today i.e. is trending at $1.23, lower by 77.76% versus the 52 week high.
How to invest in Prelude Therapeutics Stock (PRLD) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Prelude Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Prelude Therapeutics Shares that will get you 1.2195 shares as per Prelude Therapeutics share price of $1.23 per share as on August 30, 2025 at 12:38 am IST.
What is the minimum amount required to buy Prelude Therapeutics Stock (PRLD) from India?
Indian investors can start investing in Prelude Therapeutics (PRLD) shares with as little as ₹88.167 or $1 (as of August 29, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹881.67 in Prelude Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 29, 2025).
Based on Prelude Therapeutics share’s latest price of $1.23 as on August 30, 2025 at 12:38 am IST, you will get 8.1301 shares of Prelude Therapeutics. Learn more about
fractional shares .
What are the returns that Prelude Therapeutics has given to Indian investors in the last 5 years?
Prelude Therapeutics stock has given -95.08% share price returns and 20.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
Proshares Ultrapro Dow30 Etf$102.04
-0.93%
- Heartflow, Inc.
$31.10
-3.24%
Amerisafe, Inc.$46.12
+0.39%
Nuveen Tax Muni Inc$15.89
+0.25%
Calamp Corp.$1.49
+0.68%
Franklin Wireless Corp$4.44
+2.3%
- Vanguard Govt Sec Active Etf
$76.02
-0.03%
Cadrenal Therapeutics Inc$12.92
-2.78%
- Sandisk Corp
$51.08
+0.41%